Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Hodgkin Disease
×
Interleukin-2
×
Clear all
Filters
3
NCT05883449
2025-08-20
LuminICE-203
Affimed GmbH
Phase 2
Terminated
25 enrolled
21 charts
NCT00539695
2018-05-04
IL2 for GVHD
Baylor College of Medicine
Phase 2
Completed
25 enrolled
7 charts